−0.07USD
−3.18 MUSD
197.52 MUSD
48.00 M
About Vericel Corporation
Sector
CEO
Dominick C. Colangelo
Headquarters
Cambridge
Website
Employees (FY)
314
Founded
1989
ISIN
US92346J1088
FIGI
BBG000BDCM24
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VCEL is 46.26 USD — it has decreased by 2.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Vericel Corporation stocks are traded under the ticker VCEL.
Vericel Corporation is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
VCEL stock is 4.26% volatile and has beta coefficient of 1.46. Check out the list of the most volatile stocks — is Vericel Corporation there?
One year price forecast for Vericel Corporation has a max estimate of 57.00 USD and a min estimate of 47.40 USD.
VCEL earnings for the last quarter are −0.08 USD whereas the estimation was −0.12 USD which accounts for 34.00% surprise. Estimated earnings for the next quarter are 0.17 USD. See more details about Vericel Corporation earnings.
Vericel Corporation revenue for the last quarter amounts to 45.58 M USD despite the estimated figure of 45.14 M USD. In the next quarter revenue is expected to reach 63.95 M USD.
Yes, you can track Vericel Corporation financials in yearly and quarterly reports right on TradingView.
VCEL stock has fallen by 5.28% compared to the previous week, the month change is a 4.66% rise, over the last year Vericel Corporation has showed a 49.66% increase.
VCEL net income for the last quarter is 12.99 M USD, while the quarter before that showed −3.66 M USD of net income which accounts for 455.00% change. Track more Vericel Corporation financial stats to get the full picture.
Today Vericel Corporation has the market capitalization of 2.24 B, it has decreased by 2.01% over the last week.
No, VCEL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VCEL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vericel Corporation stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 314.00 employees. See our rating of the largest employees — is Vericel Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vericel Corporation technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vericel Corporation stock shows the buy signal. See more of Vericel Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Vericel Corporation future price: according to them, VCEL price has a max estimate of 57.00 USD and a min estimate of 47.40 USD. Read a more detailed Vericel Corporation forecast: see what analysts think of Vericel Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Vericel Corporation EBITDA is 663.00 K USD, and current EBITDA margin is −0.93%. See more stats in Vericel Corporation financial statements.